Reed International PLC
Elsevier NV
19 September 2001
LETTER TO COMPANY ANNOUNCEMENTS OFFICE
Issued on behalf of Reed International P.L.C. and Elsevier NV
We are writing to advise you that we have today received notification from Hill
Samuel Offshore Trust Company Limited, the Trustees of the Reed Elsevier
Employee Benefit Trust ('the Trust'), that they purchased today 580,000 ordinary
shares at an average price of 516.1284p per share in Reed International P.L.C.
They also purchased today 280,000 ordinary shares at an average price of
EUR11.5785 per share in Elsevier NV.
Following these purchases, the Trust now holds 2,417,924 ordinary shares in Reed
International P.L.C. and 1,413,442 ordinary shares in Elsevier NV.
The Trust is a discretionary employee benefit trust which is operated in
conjunction with Reed Elsevier's share option schemes, and which provides for
the transfer of shares to employees on the exercise of options granted under the
said schemes. Executive directors of Reed International P.L.C. and Elsevier NV
are, for technical disclosure purposes, deemed to be interested in the shares
held by the Trust, by virtue of being potential beneficiaries under the Trust.
FROM REED ELSEVIER
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.